These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 34666951

  • 1. Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system.
    Jia X, Lee MT, Ramsey DJ, Mahtta D, Akeroyd JM, Turchin A, Navar AM, Matheny ME, Gobbel G, Stone NJ, Nambi V, Ballantyne CM, Petersen LA, Virani SS.
    J Clin Lipidol; 2021; 15(6):832-839. PubMed ID: 34666951
    [Abstract] [Full Text] [Related]

  • 2. Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System.
    Jia X, Lee MT, Ramsey DJ, Al Rifai M, Mahtta D, Krittanawong C, Akeroyd JM, Matheny ME, Gobbel G, Stone NJ, Ballantyne CM, Petersen LA, Virani SS.
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):295-300. PubMed ID: 33523335
    [Abstract] [Full Text] [Related]

  • 3. The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs.
    Virani SS, Akeroyd JM, Ahmed ST, Krittanawong C, Martin LA, Slagle J, Gobbel GT, Matheny ME, Ballantyne CM, Petersen LA.
    J Clin Lipidol; 2019 Apr; 13(5):797-803.e1. PubMed ID: 31501043
    [Abstract] [Full Text] [Related]

  • 4. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
    Lee MT, Mahtta D, Ramsey DJ, Liu J, Misra A, Nasir K, Samad Z, Itchhaporia D, Khan SU, Schofield RS, Ballantyne CM, Petersen LA, Virani SS.
    JAMA Cardiol; 2021 Jul 01; 6(7):782-790. PubMed ID: 33881448
    [Abstract] [Full Text] [Related]

  • 5. Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System).
    Rehman H, Ahmed ST, Akeroyd J, Mahtta D, Jia X, Rifai MA, Nasir K, Jneid H, Khalid MU, Alam M, Toth PP, Virani SS.
    Am J Cardiol; 2019 Oct 15; 124(8):1165-1170. PubMed ID: 31405545
    [Abstract] [Full Text] [Related]

  • 6. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S, Papaila A, Halladay C, Ge A, Liu MA, Jiang L, Lally M, Menon A, Shah NR, Miech E, Virani SS, Zullo AR, Shireman TI, Longenecker CT, Ross D, Sullivan JL, Wu WC, Rudolph JL.
    Am Heart J; 2022 Jul 15; 249():12-22. PubMed ID: 35318028
    [Abstract] [Full Text] [Related]

  • 7. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA.
    JAMA Cardiol; 2017 Jan 01; 2(1):47-54. PubMed ID: 27829091
    [Abstract] [Full Text] [Related]

  • 8. Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.
    Pokharel Y, Akeroyd JM, Ramsey DJ, Hira RS, Nambi V, Shah T, Woodard LD, Winchester DE, Ballantyne CM, Petersen LA, Virani SS.
    Clin Cardiol; 2016 Apr 01; 39(4):185-91. PubMed ID: 27059708
    [Abstract] [Full Text] [Related]

  • 9. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA.
    JAMA Cardiol; 2019 Mar 01; 4(3):206-213. PubMed ID: 30758506
    [Abstract] [Full Text] [Related]

  • 10. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR, Driver JA, Ho YL, Lu B, Costa L, Honerlaw J, Galloway A, Vassy JL, Forman DE, Gaziano JM, Gagnon DR, Wilson PWF, Cho K, Djousse L.
    JAMA; 2020 Jul 07; 324(1):68-78. PubMed ID: 32633800
    [Abstract] [Full Text] [Related]

  • 11. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
    Mahtta D, Lee MT, Ramsey DJ, Akeroyd JM, Krittanawong C, Khan SU, Sinh P, Alam M, Garratt KN, Schofield RS, Ballantyne CM, Petersen LA, Virani SS.
    Cardiovasc Drugs Ther; 2022 Feb 07; 36(1):93-102. PubMed ID: 33400053
    [Abstract] [Full Text] [Related]

  • 12. An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems.
    Ward R, Weeda ER, Bishu KG, Axon RN, Taber DJ, Gebregziabher M.
    J Manag Care Spec Pharm; 2020 Sep 07; 26(9):1090-1098. PubMed ID: 32857659
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL, Lu B, Ho YL, Galloway A, Raghavan S, Honerlaw J, Tarko L, Russo J, Qazi S, Orkaby AR, Tanukonda V, Djousse L, Gaziano JM, Gagnon DR, Cho K, Wilson PWF.
    JAMA Netw Open; 2020 Jul 01; 3(7):e208236. PubMed ID: 32662843
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.
    Mahtta D, Ramsey DJ, Al Rifai M, Nasir K, Samad Z, Aguilar D, Jneid H, Ballantyne CM, Petersen LA, Virani SS.
    JAMA Netw Open; 2020 Aug 03; 3(8):e2011051. PubMed ID: 32816031
    [Abstract] [Full Text] [Related]

  • 17. Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.
    Ahmed ST, Akeroyd JM, Mahtta D, Street R, Slagle J, Navar AM, Stone NJ, Ballantyne CM, Petersen LA, Virani SS.
    J Am Heart Assoc; 2020 Nov 17; 9(22):e017915. PubMed ID: 33170055
    [Abstract] [Full Text] [Related]

  • 18. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.
    Anderson JL, Knowlton KU, May HT, Bair TL, Armstrong SO, Lappé DL, Muhlestein JB.
    J Clin Lipidol; 2018 Nov 17; 12(4):1008-1018.e1. PubMed ID: 29703626
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.